跳至主要内容
临床试验/NCT02013024
NCT02013024已完成不适用

The Effect of Vitrification Versus Slow Freezing on Day 3: a Randomised Controlled Trial.

Sophie Debrock2 个研究点 分布在 1 个国家目标入组 417 人开始时间: 2011年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
417
试验地点
2
主要终点
Life birth rate per embryo thawed

研究概览

简要总结

Randomized controlled trial (RCT) testing the hypothesis that vitrification is superior to slow freezing.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients (with female age < 40 years)
  • Patients undergoing a 1st oocyte retrieval for an IVF/Intracytoplasmatic Sperm Injection (ICSI) treatment
  • Patients planned for an embryo transfer on day
  • Patients with supernumerary embryos of sufficient quality for freezing/vitrifying on day
  • Fresh personal (own oocytes)
  • One inclusion in the study per patient.

排除标准

  • Patients undergoing a 2nd or higher ranked oocyte retrieval after a fresh cycle with failed pregnancy.
  • Female age ≥ 40 year
  • Patients with Preimplantation Genetic Diagnosis (PGD)
  • Patients with donor oocytes
  • Patients with positive serology whose embryos may not be frozen.
  • Patients planned for a transfer on day 2 or day
  • Patients receiving assisted hatching in the embryo transfer in the frozen cycles.
  • Patients who have been included in the study before.

结局指标

主要结局

Life birth rate per embryo thawed

时间窗: 3 years

次要结局

  • survival rate(3 year)
  • live birth rate per embryo transferred(3)
  • implantation rate per embryo thawed(3 years)
  • abortion rate(3 years)
  • implantation rate per embryo transferred(3 years)

研究者

发起方
Sophie Debrock
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Sophie Debrock

clinical embryologist PhD

KU Leuven

研究点 (2)

Loading locations...

相似试验